Recall: Albuterol Sulfate
Jul. 2023Pharmacy Updates
Cipla US is recalling six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation), manufactured in November 2021. They initiated the recall because of a complaint where leakage was observed through the inhaler’s inhaler valve. This drug is used to treat asthma and to prevent exercise-induced asthma. Read the full text of the Albuterol Sulfate recall.
Recent Announcements
Special notice: Important policy changes
Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.May 2025Important Notices
Provider OnLine Enhancements
Provider OnLine will be launching enhancements to the authorization process on April 18, 2025. The enhancement will include the following updates:Apr. 2025Important Notices
Fostering Trust in Vaccinations Through Shared Decision Making
Please join us for a live, CME-accredited webinar on Wednesday, June 4, from noon to 1 p.m. that will provide an overview of fostering trust in vaccinations through shared decision making.Apr. 2025Education/Webinars